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In patients with complete venous occlusion requiring venous access for cardiac device lead placement,
venous revascularization is a viable option. A percutaneous approach to venous revascularization has
gained popularity. This method reduces patient exposure to more invasive therapies. In this case series,
we describe two cases of a total venous occlusion that were successfully revascularized using a “wire
externalization” technique. This technique requires the use of antegrade and retrograde access.
Copyright © 2016, Indian Heart Rhythm Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Upper extremity transvenous access is the method of choice for
implantation of cardiac implantable electronic devices (CIED).
However, venous access for many patients can be challenging and
not achievable due to vessel occlusion. The most common cause of
venous occlusion is prior instrumentation [1e4].
In patients requiring CIEDs, venous occlusion is usually recog-
nized with venography prior to device insertion. If left-sided
venous access is unavailable, contralateral venous access or an
epicardial approach to device placement can be performed.
Epicardial lead placement is an invasive procedure requiring a
mini-thoracotomy. There can be associated complications such as
infection, post-procedural pain, and the need for repeat procedures
[1]. Right sided access can be technically more challenging for lead
placement. In addition, the recovery post-procedure is more difﬁ-
cult for the right-handed patient.
Percutaneous techniques for safe revascularization of stenotic
veins can reduce both the need for more invasive procedures as
well as the risk of harm to patients. Techniques for angioplasty in
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occlusion who underwent venoplasty and successful lead place-
ment. A single chamber, VVI pacemaker was implanted successfully
in one patient. The second patient had an implantable cardioverter
deﬁbrillator (ICD) upgraded to a cardiac resynchronization therapy-
deﬁbrillator device (CRT-D) with the addition of a left ventricular
lead. The procedures were done using a “Heart Team Approach”
with physicians and staff experienced in coronary CTO techniques
as well as complex CIED's to ensure optimal safety and success.
2. Case 1
An 84 year old male on hemodialysis via a right upper limb
ﬁstula presented with syncope. A 12 lead electrocardiogram
demonstrated sinus rhythm with 2 to 1 atrioventricular block and
he was offered a permanent pacemaker (PPM). Prior to device
insertion, left upper limb venography revealed an occluded left
subclavian vein (Fig. 1A). As the right subclavian vein was required
for hemodialysis, it was decided to attempt venoplasty of the left
subclavian vein.
The procedurewas a collaborative effort between interventional
cardiology and electrophysiology with both teams present in the
cardiac catheterization lab.
The left subclavian vein and right femoral vein were accessed
with 7 and 8 French sheaths respectively, to establish access on
both sides of the stenosis. Simultaneous dual injections were per-
formed with a multipurpose guide catheter in the left subclavian
and a pigtail catheter in the superior vena cava (SVC) (Fig. 1A). ThisElsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 1. A. Pig tail catheter in the SVC(solid arrow) and multipurpose guide catheter in the left subclavian vein (dashed arrow) with simultaneous contrast injection showing a long
venous occlusion B. Conﬁanza PRO 12 wire (solid arrow) entering the true lumen of the SVC C. R350 externalization wire being snared (solid arrow) D. Snared R350 wire being
pulled into the guide catheter E. Retrograde noncompliant balloon (solid arrow) dilation of the stenotic vein F. Pacemaker lead (solid arrow) being advanced through a SafeSheath.
M. Golian et al. / Indian Pacing and Electrophysiology Journal xxx (2016) 1e42revealed a long venous total occlusionwith an ambiguous proximal
and distal cap (Fig. 1A).
Using the femoral vein access site, a Finecross® MG coronary
micro-guide catheter (Terumo Europe NV) was advanced near the
distal cap and it was then punctured. The Finecross® was then
advanced into the cap. A HI-TORQUE PILOT 200 guidewire (Abbott
Vascular, USA) was used to cross to the occluded segment, but was
unable to successfully puncture the distal cap. The Finecross® was
advanced to the distal cap and an ASAHI® Conﬁanza PRO 12 (ASAHI
Intecc Co., Ltd) was used to puncture the distal cap and the Fine-
cross® catheter was subsequently placed over an R350 300 cm
guidewire (Vascular Solutions, USA) into the SVC. (Fig. 1B).
An EN Snare® 120 cm (18e30 mm snare diameter) (Merit
Medical Systems, Inc.) endovascular snare was used to snare thePlease cite this article in press as: Golian M, et al., Venoplasty of a chronic
approach, Indian Pacing and Electrophysiology Journal (2016), http://dx.R350 which was then externalized (Fig. 1C and D).
Retrograde angioplasty was performed using progressively
larger non-compliant balloons (up to 5  20 mm), to facilitate
antegrade advancement of a QUICK-CROSS® support catheter
(Spectranetics) into the SVC (Fig. 1E). The externalized R350 wire
was then removed and exchanged for an Amplatz support wire
(Cook Medical).
A 25 cm 7 French SafeSheath® (Pressure Products Medical
Supplier, Inc.) was then placed antegradely over the Amplatz sup-
port wire. A 4076 58 cm active ﬁxation lead (Medtronic Inc., Min-
neapolis, USA) was then placed into the right ventricular apex and
connected to a Sensia SESR01 (Medtronic) (Fig. 1F). The pocket was
closed in the usual fashion and the femoral vein catheter was
removed. There were no early complications.venous occlusion allowing for cardiac device lead placement: A team
doi.org/10.1016/j.ipej.2016.11.007
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A 57 yo male with an ischemic cardiomyopathy, New York Heart
Association (NYHA) functional class III symptoms, and an ejection
fraction of 30%, had an ICD inserted 6 years previously for sec-
ondary prevention of sudden cardiac death. The ICD generator now
requires replacing due to battery depletion. A 12 lead ECG revealed
an underlying left bundle branch block with a QRS duration of 170
msec so it was decided to upgraded his ICD to a CRT-D. Left upper
limb venography documented occlusion of the left subclavian vein
(Fig. 2A).
Using a team approach similar to the ﬁrst case, access on both
sides of the stenotic vein was obtained using the left subclavian
vein, right femoral vein, and right antecubital vein. Using the rightFig. 2. A. Proximal site to subclavian stenosis (solid arrow) and distal cap of stenotic lesion
arrow) entering the true lumen of the innominate vein, JR4 guide (solid arrow) C. Uninﬂated
the stenotic lesion E. Contrast injection in the cannulated coronary sinus F. Lateral cardiac
Please cite this article in press as: Golian M, et al., Venoplasty of a chronic
approach, Indian Pacing and Electrophysiology Journal (2016), http://dx.dfemoral vein access, a Judkins Right size 4 (JR4) guiding catheter
was advanced under ﬂuoroscopic guidance into the left innominate
vein. Through the antecubital access, a JR4 guiding catheter was
also advanced to the level of the left subclavian vein occlusion. A
Conﬁanza PRO 12 was advanced successfully past the occlusion and
into the distal segment of the vessel from the left subclavian access
site (Fig. 2B). The wire was then advanced into the right ventricle
conﬁrming a ‘true lumen to true lumen’ connection. The CTO lesion
was then dilated with progressively larger balloons from a
1.25  15 mm compliant balloon to a 5  20 mm noncompliant
balloon (Fig. 2C and D). Following the angioplasty, a QUICK-CROSS®
support catheter and an Amplatz Super Stiff™ guidewire (Boston
Scientiﬁc Corp.) were placed into the right atrium. A 9 French
SafeSheath® was then inserted over the Amplatz Super Stiff™(dashed arrow) seen with bilateral contrast injection B. Conﬁanza PRO 12 wire (dashed
compliant balloon (solid arrow) D. Inﬂated 5  20 mm non-compliant balloon crossing
vein cannulated using LV lead (Solid arrow).
venous occlusion allowing for cardiac device lead placement: A team
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(Medtronic Inc.) was advanced into the right atrium. Using a Mar-
inr® catheter (Medtronic Inc.), the coronary sinus was cannulated
and injection of 10 cc of Visipaque revealed a narrow posterolateral
vein and small lateral vein (Fig. 2E). A Medtronic 4396-88 cm dual
electrode lead was successfully placed in the lateral vein (Fig. 2F).
The existing right atrial and right ventricular leads had good sense/
pace characteristics and stable impedance measurements. A CRT-D
was connected to all 3 leads and placed in the pocket. There were
no early complications.
4. Discussion
Venous access for placement of CIED's can be challenging. Uti-
lization of stenotic veins is increasingly required to deliver optimal
care and minimize invasive procedures.
Venous occlusion can be divided into two types, primary and
secondary. Primary venous stenosis occurs in the absence of prior
instrumentation or external compression. It can be due to venous
thrombosis, either idiopathic or secondary to predisposing factors
conditions such as thrombophilias or hormone therapy. Secondary
stenosis, seen in patients with prior venous instrumentation or
with external vein compression, can occur due to impingement of
the subclavian vein between the ﬁrst rib and the clavicle (‘subcla-
vian crush’). Other predisposing risks include prior instrumenta-
tion, which can result in vessel wall damage, inﬂammation and
promotion of thrombogenesis [2,3].
In a retrospective study by Ji and colleagues, the rate of venous
stenosis was as high as 5% [3]. In a consecutive series of 105 patients
presenting for their ﬁrst generator replacement, 9% had complete
occlusion of the insertion vein and a further 16% had at least a
moderate stenosis [4]. Worley et al. showed that two thirds of
encountered stenoses occur at the subclavian to distal innominate
vein junction with a total angiographic occlusion rate of 20% [5].
When a total venous occlusion is encountered options include:
1) puncturing proximal to the site of stenosis if possible; 2) aban-
doning and obtaining access on the contralateral side or an alter-
native site such as the femoral vein; 3) epicardial implantation
through a thoracotomy; and 4) venoplasty.
In patients with venous occlusion, contralateral access or
proximal puncture is not always feasible. The contralateral side
may be used for other lifesaving procedures such as dialysis and
proximal venous puncture may not be safely performed. Veno-
plasty can offer a viable option in such cases.
Post balloon dilation of the venous stenosis, stenting can be
considered if primary balloon angioplasty fails or long-term
patency is desired. Unlike arterial stents that lead to improved
long-term vessel patency, results are mixed in venous stenting. In a
study including 146 stenosed veins, there was a higher primaryPlease cite this article in press as: Golian M, et al., Venoplasty of a chronic
approach, Indian Pacing and Electrophysiology Journal (2016), http://dx.patency rate with venoplasty alone (24%) compared to stenting
(13%) [6].
In case 1, immediate vessel patency was required for lead
placement and as the patient did not have any symptoms due to the
venous stenosis, stenting was not performed. In case 2, stenting
was not possible due to the presence of previous leads which could
result in stent malapposition and intraluminal thrombosis as well
as the possibility of damage to the leads. Subclavian venous stent
placement complications also include overlap of the stent with the
internal jugular vein which would limit future central line place-
ment; occlusion of the contralateral brachiocephalic or other
venous branches causing superior vena cava or brachiocephalic
vein syndrome. Systemic anticoagulationwas not required in either
case.
To improve procedural success and reduce the complication risk
we chose a collaborative approach with interventional skills in total
vessel occlusion as well as electrophysiology skills in device
implantation.5. Conclusion
Total venous occlusion is an increasingly common problem
encountered at the time of device implantation. Revascularization
of the occluded vein can be achieved safely using a collaborative
team approach.Disclosures
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